Home LiteratureArticle Details
PMID: 33718347 Published · epublish English Journal Article

Increased Tumor Immune Microenvironment CD3+ and CD20+ Lymphocytes Predict a Better Prognosis in Oral Tongue Squamous Cell Carcinoma.

Frontiers in cell and developmental biology ·Vol. 8 ·2020-00-00 ·Pages 622161

Sales de Sá R, Miranda Galvis M, Mariz BALA, Leite AA, Schultz L, Almeida OP, Santos-Silva AR, Pinto CAL, Vargas PA, Gollob KJ, Kowalski LP

Abstract

Background: Oral tongue squamous cell carcinoma (OTSCC) causes over 350,000 cases annually and particularly impacts populations in developing countries. Smoking and alcohol consumption are major risk factors. Determining the role of the tumor immune microenvironment (TIME) in OTSCC outcomes can elucidate immune mechanisms behind disease progression, and can potentially identify prognostic biomarkers. Methods: We performed a retrospective study of 48 OTSCC surgical specimens from patients with tobacco and alcohol exposures. A panel of immunoregulatory cell subpopulations including T (CD3, CD4, CD8) and B (CD20) lymphocytes, dendritic cells (CD1a, CD83), macrophages (CD68), and immune checkpoint molecules programmed cell death protein 1 (PD-1) and ligand 1 (PD-L1) were analyzed using immunohistochemistry. The levels of immune effector cell subpopulations and markers were analyzed in relation to overall survival. Results: Pathological characteristics of the tumor microenvironment included inflammatory infiltrates (83.3%), desmoplasia (41.6%), and perineural invasion (50.0%). The TIME contained high levels of T cells (CD3+, CD4+, and CD8+) and B cells (CD20+), as well as immature (CD1a) and mature (CD83) dendritic cells, PD-1, and PD-L1. Higher numbers of TIME infiltrating CD3+ T cells and CD20+ B cells were predictive of better survival, while higher levels of CD83+ mature dendritic cells predicted better survival. CD3+ T cells were identified as an independent prognostic marker for OTSCC. Lastly, CD3+ T cells were strongly correlated with the number of CD8+ cells and PD-L1 expression. Conclusion: Our findings provide evidence that the TIME profile of OTSSC impacted prognosis. The high expression of CD3+ T cells and B cells are predictive of better overall survival and indicative of an immunologically active, inflammatory TIME in patients with better survival. The number of CD3+ T cells was an independent prognostic marker.

Keywords
CD20 B cells+ CD3 immune microenvironment tongue squamous cell carcinoma (TSCC) tumor-infiltrating lymphocytes
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Sales de Sá Raísa
Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Miranda Galvis Marisol
Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil. | Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA, United States.
Mariz Bruno Augusto Linhares Almeida
Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Leite Amanda Almeida
Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Schultz Luciana
Department of Anatomic Pathology, Instituto de Anatomia Patologica-IAP, Santa Barbara d'Oeste, Brazil.
Almeida Oslei Paes
Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Santos-Silva Alan Roger
Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Pinto Clovis Antonio Lopes
Department of Anatomic Pathology, A. C. Camargo Cancer Center, São Paulo, Brazil.
Vargas Pablo Agustin
Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Gollob Kenneth John
International Research Center, A. C. Camargo Cancer Center, São Paulo, Brazil. | National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, A.C. Camargo Cancer Center, São Paulo, Brazil.
Kowalski Luiz Paulo
Department of Head and Neck Surgery and Otorhinolaryngology, A. C. Camargo Cancer Center, São Paulo, Brazil. | Head and Neck Surgery Department, Medical School, University of São Paulo, São Paulo, Brazil.
Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References (44)
44 references, click to expand
  1. Density and location of CD3+ and CD8+ tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma.
    J Oral Pathol Med. 2018 Apr;47(4):359-367 PMID: 29469989
  2. CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma.
    J Oral Pathol Med. 2016 Jul;45(6):433-9 PMID: 26661374
  3. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence.
    Pathol Oncol Res. 2020 Apr;26(2):735-742 PMID: 30767115
  4. Cancer immunoediting from immune surveillance to immune escape.
    Immunology. 2007 May;121(1):1-14 PMID: 17386080
  5. PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.
    Cancer Res. 2017 Nov 15;77(22):6353-6364 PMID: 28904066
  6. The role of dendritic cells in cancer.
    Semin Immunopathol. 2017 Apr;39(3):307-316 PMID: 27638181
  7. High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma.
    PLoS One. 2015 Nov 12;10(11):e0142656 PMID: 26562534
  8. Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.
    Virchows Arch. 2019 Apr;474(4):463-474 PMID: 30631935
  9. Staging and grading of oral squamous cell carcinoma: An update.
    Oral Oncol. 2020 Aug;107:104799 PMID: 32446214
  10. Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study.
    Head Neck. 2017 Feb;39(2):297-304 PMID: 27696557
  11. Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis.
    Oral Oncol. 2020 Jul;106:104722 PMID: 32330687
  12. PD1 signal transduction pathways in T cells.
    Oncotarget. 2017 Apr 19;8(31):51936-51945 PMID: 28881701
  13. Macrophages and prognosis of oral squamous cell carcinoma: A systematic review.
    J Oral Pathol Med. 2018 May;47(5):460-467 PMID: 28940738
  14. Tumor-infiltrating CD8+ T-cell density is an independent prognostic marker for oral squamous cell carcinoma.
    Cancer Med. 2019 Jan;8(1):80-93 PMID: 30600646
  15. Hallmarks of cancer: the next generation.
    Cell. 2011 Mar 4;144(5):646-74 PMID: 21376230
  16. Immunology and Immunotherapy of Head and Neck Cancer.
    J Clin Oncol. 2015 Oct 10;33(29):3293-304 PMID: 26351330
  17. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
    Head Neck. 2016 Jul;38(7):1074-84 PMID: 26879675
  18. Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma.
    J Dent Res. 2018 Jun;97(6):622-626 PMID: 29489423
  19. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.
    J Immunother Cancer. 2018 Jan 23;6(1):8 PMID: 29357948
  20. Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma.
    BMC Clin Pathol. 2014 Aug 23;14:38 PMID: 25177210
  21. Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis.
    Br J Cancer. 2019 Apr;120(7):714-727 PMID: 30808992
  22. Cancer classification using the Immunoscore: a worldwide task force.
    J Transl Med. 2012 Oct 03;10:205 PMID: 23034130
  23. Oral squamous cell carcinoma overview.
    Oral Oncol. 2009 Apr-May;45(4-5):301-8 PMID: 19249237
  24. The immune microenvironment of human tumors: general significance and clinical impact.
    Cancer Microenviron. 2013 Aug;6(2):117-22 PMID: 23108700
  25. Immunosurveillance profile of oral squamous cell carcinoma and oral epithelial dysplasia through dendritic and T-cell analysis.
    J Oral Pathol Med. 2017 Nov;46(10):928-933 PMID: 28585308
  26. Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2020 Mar 15;26(6):1474-1485 PMID: 31848186
  27. Clinicopathological and prognostic significance of PD-1/PD-L1 axis expression in patients with tongue squamous cell carcinoma.
    J Cell Physiol. 2020 Oct;235(10):6942-6953 PMID: 32030768
  28. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.
    Ann Surg Oncol. 2010 Jun;17(6):1471-4 PMID: 20180029
  29. PD-L1 expression patterns in oral cancer as an integrated approach for further prognostic classification.
    Oral Dis. 2020 Nov 10;: PMID: 33169454
  30. An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.
    Int J Cancer. 2016 Jun 15;138(12):2952-62 PMID: 26815146
  31. Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy.
    Transl Oncol. 2020 Feb;13(2):262-274 PMID: 31869751
  32. Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer.
    Cancer Med. 2012 Oct;1(2):128-40 PMID: 23342263
  33. Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection.
    Int J Cancer. 2020 Feb 15;146(4):1152-1163 PMID: 31304591
  34. Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: A systematic review and meta-analysis.
    Crit Rev Oncol Hematol. 2020 Jun;150:102966 PMID: 32371338
  35. PD-L1 Expression in Tumor Cells Is an Independent Unfavorable Prognostic Factor in Oral Squamous Cell Carcinoma.
    Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):546-554 PMID: 30487133
  36. CD20+ Tumor Infiltrating B Lymphocyte in Oral Squamous Cell Carcinoma: Correlation with Clinicopathologic Characteristics and Heat Shock Protein 70 Expression.
    Patholog Res Int. 2018 Apr 4;2018:4810751 PMID: 29850009
  37. Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma.
    Med Oncol. 2019 Jan 21;36(2):21 PMID: 30666437
  38. The hallmarks of cancer.
    Cell. 2000 Jan 7;100(1):57-70 PMID: 10647931
  39. Immune suppressive mechanisms in the tumor microenvironment.
    Curr Opin Immunol. 2016 Apr;39:1-6 PMID: 26609943
  40. A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma.
    Histopathology. 2018 May;72(6):905-913 PMID: 29023924
  41. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    CA Cancer J Clin. 2018 Nov;68(6):394-424 PMID: 30207593
  42. Depletion of Langerhans cells in the tongue from patients with advanced-stage acquired immune deficiency syndrome: relation to opportunistic infections.
    Histopathology. 2012 Feb;60(3):497-503 PMID: 22168427
  43. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
    Exp Cell Res. 2014 Jul 15;325(2):58-64 PMID: 24462456
  44. Inflammatory breast cancer biology: the tumour microenvironment is key.
    Nat Rev Cancer. 2018 Aug;18(8):485-499 PMID: 29703913
Full Text / Full Text
PMC full text available locally, click to read

Loading full text...

Article Info
Journal
Frontiers in cell and developmental biology
Abbr.
Front Cell Dev Biol
ISSN
2296-634X
Published
2020-00-00
Epub
2021-00-18
Pages
622161
Language
English
Region
Switzerland
NLM ID
101630250
PMCID
PMC7951138
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com